| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444939 | European Journal of Cancer | 2013 | 9 Pages |
Abstract
For a contemporary cohort of patients with high-risk extremity and truncal STS, a regimen of neoadjuvant chemoradiotherapy and surgery continues to result in high rates of survival with tolerable short- and long-term toxicity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nicole J. Look Hong, Francis J. Hornicek, David C. Harmon, Edwin Choy, Yen-Lin Chen, Sam S. Yoon, G. Petur Nielsen, Jackie Szymonifka, Beow Y. Yeap, Thomas F. DeLaney, John T. Mullen,